Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4)
Latest & greatest articles for beclomethasone
The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on beclomethasone or other clinical topics then use Trip today.
This page lists the very latest high quality evidence on beclomethasone and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.
What is Trip?
Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.
Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.
As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.
For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via email@example.com
Inhaled beclomethasone versus placebo for chronic asthma. BACKGROUND: Inhaled beclomethasone diproprionate (BDP) has been, together with inhaled budesonide, the mainstay of anti-inflammatory therapy for asthma for many years. A range of new prophylactic therapies for asthma is becoming available and BDP is now frequently used as the reference treatment against which these newer agents are being compared. OBJECTIVES: The objectives of this review were to: a) Compare the efficacy of BDP
A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group. 9385125 1997 12 04 1997 12 04 2015 11 19 0028-4793 337 23 1997 Dec 04 The New England journal of medicine N. Engl. J. Med. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group. 1659-65 An inhaled glucocorticoid is currently the medication of choice (...) for long-term control of persistent asthma in children. The role of long-acting beta2-adrenergic-receptor agonists, such as salmeterol, needs to be defined. We conducted a randomized, double-blind, placebo-controlled, parallel-group, one-year study of 241 children (mean [+/-SD] age, 9.3+/-2.4 years) with clinically stable asthma and less than one month of prior glucocorticoid use. We compared inhaled beclomethasone dipropionate (200 microg twice daily) with salmeterol xinafoate (50 microg twice daily
Cough and wheezing from beclomethasone dipropionate aerosol are absent after triamcinolone acetonide. Cough and wheezing from beclometh... preview & related info | Mendeley E-mail address Password ( ) Remember me …or sign in with Search Main Navigation › Short URL Annals of Internal Medicine ( 1987 ) Volume: 106 , Issue: 5 , Pages: 700-703 PubMed: Available from or Find this paper at: Abstract Study Objective: To test the hypothesis that patients with asthma who develop cough and wheezing after (...) the use of beclomethasone aerosol would have a better tolerance for triamcinolone aerosol. Design: Randomized, double-blinded, crossover trial. Setting: Pulmonary function laboratory. Patients: Volunteer sample of 24 patients attending an asthma clinic who had developed cough, with or without wheezing, after inhaling beclomethasone aerosol. All patients completed the study. Interventions: Aerosols were used in habitual manufacturers' preparations and canisters, but both were administered in three
Combined therapy with salbutamol and beclomethasone inhalers in chronic asthma. 78297 1978 08 28 1978 08 28 2015 06 16 0140-6736 2 8080 1978 Jul 08 Lancet (London, England) Lancet Combined therapy with salbutamol and beclomethasone inhalers in chronic asthma. 70-2 A double-blind cross-over trial was carried out to compare the effect of identical placebo with that of salbutamol inhalers used 30 min before inhalation of 100 microgram of beclomethasone dipropionate (B.D.P.) in 18 chronic (...) asthmatics over two consecutive 4-week periods. The salbutamol and B.D.P. combination resulted in a significant improvement in the peak expiratory flow-rate and F.E.V.1, significantly less use of the rescue inhaler, and better control. Clark R A RA Anderson P B PB eng Clinical Trial Comparative Study Journal Article Randomized Controlled Trial England Lancet 2985213R 0140-6736 0 Aerosols 0 Placebos KGZ1SLC28Z Beclomethasone QF8SVZ843E Albuterol AIM IM Adult Aerosols Aged Albuterol administration & dosage